PulmonarOM (Bacterial Lysates) in Respiratory Tract Infections

Summary

Primary \- To evaluate the efficacy of Pulmonaron in the decrease of interleukin-4/interferon gamma after second period of treatment Secondary * To evaluate the efficacy of Pulmonarom in the prevention of upper respiratory tract infections symptoms through patient evaluation of fever or respiratory presence after second period of treatment * To evaluate loss of working or study days after second period of treatment * To evaluate the safety and tolerability of Pulmonarom in the population under study

Timeline

Start

2007-12

Primary completion

2008-09

Completion

2008-09

Drugs

Indications